541 related articles for article (PubMed ID: 25726381)
1. Antithrombotic strategies and outcomes in acute coronary syndrome with atrial fibrillation.
Chamberlain AM; Gersh BJ; Mills RM; Klaskala W; Alonso A; Weston SA; Roger VL
Am J Cardiol; 2015 Apr; 115(8):1042-8. PubMed ID: 25726381
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome in the real world: Data from the Berlin AFibACS Registry.
Maier B; Hegenbarth C; Theres H; Schoeller R; Schuehlen H; Behrens S;
Cardiol J; 2014; 21(5):465-73. PubMed ID: 24142683
[TBL] [Abstract][Full Text] [Related]
3. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
[TBL] [Abstract][Full Text] [Related]
4. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].
Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427
[No Abstract] [Full Text] [Related]
5. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
[TBL] [Abstract][Full Text] [Related]
6. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation in acute coronary syndrome: patient characteristics and appropriate utilisation of anti-thrombotic therapy in New Zealand (ANZACS-QI 39).
Ho CY; Nunn C; White J; Kerr A; Lee M
N Z Med J; 2020 Jul; 133(1519):41-54. PubMed ID: 32777794
[TBL] [Abstract][Full Text] [Related]
8. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
[TBL] [Abstract][Full Text] [Related]
9. Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2.0) for stroke prevention in atrial fibrillation.
Wang Y; Bajorek B
Cardiol J; 2017; 24(2):176-187. PubMed ID: 28070883
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological therapy following acute coronary syndromes in patients with atrial fibrillation: how do we balance ischaemic risk with bleeding risk?
Fake AL; Harding SA; Matsis PP; Larsen PD
N Z Med J; 2016 May; 129(1435):39-49. PubMed ID: 27355167
[TBL] [Abstract][Full Text] [Related]
11. Impact of atrial fibrillation and inadequate antithrombotic management on mortality in acute neurovascular syndrome.
Saarinen JT; Rusanen H; Sillanpää N; Huhtala H; Numminen H; Elovaara I
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2256-64. PubMed ID: 25156784
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study.
Petersen JK; Butt JH; Yafasova A; Torp-Pedersen C; Sørensen R; Kruuse C; Vinding NE; Gundlund A; Køber L; Fosbøl EL; Østergaard L
Int J Cardiol; 2024 Jul; 407():132017. PubMed ID: 38588863
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
15. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
Mitchell LB; Southern DA; Galbraith D; Ghali WA; Knudtson M; Wilton SB;
Heart; 2014 Oct; 100(19):1524-30. PubMed ID: 24860007
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
17. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
18. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
Reddy P; Giugliano RP
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084
[TBL] [Abstract][Full Text] [Related]
19. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.
Lopes RD; White JA; Atar D; Keltai M; Kleiman NS; White HD; Widimsky P; Zeymer U; Giugliano RP; Tricoci P; Braunwald E; Bode C; Ohman EM; Armstrong PW; Newby LK
Int J Cardiol; 2013 Oct; 168(3):2510-7. PubMed ID: 23578889
[TBL] [Abstract][Full Text] [Related]
20. Dual-Antithrombotic Therapy With DOACs After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.
Shurrab M; Danon A; Alnasser S; Glover B; Kaoutskaia A; Henderson M; Newman D; Crystal E; Ko D
Can J Cardiol; 2020 Jan; 36(1):135-142. PubMed ID: 31874747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
